Logo image of AKZA.AS

AKZO NOBEL N.V. (AKZA.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:AKZA - NL0013267909 - Common Stock

56.52 EUR
+0.52 (+0.93%)
Last: 12/12/2025, 1:25:35 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AKZA. AKZA was compared to 72 industry peers in the Chemicals industry. While AKZA is still in line with the averages on profitability rating, there are concerns on its financial health. AKZA has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AKZA was profitable.
AKZA had a positive operating cash flow in the past year.
In the past 5 years AKZA has always been profitable.
In the past 5 years AKZA always reported a positive cash flow from operatings.
AKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFAKZA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

AKZA has a Return On Assets (0.42%) which is in line with its industry peers.
AKZA's Return On Equity of 1.48% is in line compared to the rest of the industry. AKZA outperforms 47.22% of its industry peers.
The Return On Invested Capital of AKZA (3.70%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AKZA is in line with the industry average of 7.08%.
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROIC 3.7%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
AKZA.AS Yearly ROA, ROE, ROICAKZA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

AKZA has a Profit Margin (0.56%) which is in line with its industry peers.
In the last couple of years the Profit Margin of AKZA has declined.
Looking at the Operating Margin, with a value of 4.84%, AKZA is in line with its industry, outperforming 50.00% of the companies in the same industry.
AKZA's Operating Margin has been stable in the last couple of years.
The Gross Margin of AKZA (39.78%) is comparable to the rest of the industry.
AKZA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
AKZA.AS Yearly Profit, Operating, Gross MarginsAKZA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

AKZA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for AKZA remains at a similar level compared to 1 year ago.
AKZA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for AKZA has been reduced compared to a year ago.
AKZA.AS Yearly Shares OutstandingAKZA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AKZA.AS Yearly Total Debt VS Total AssetsAKZA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.03 indicates that AKZA is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.03, AKZA is not doing good in the industry: 63.89% of the companies in the same industry are doing better.
AKZA has a debt to FCF ratio of 10.17. This is a negative value and a sign of low solvency as AKZA would need 10.17 years to pay back of all of its debts.
AKZA's Debt to FCF ratio of 10.17 is in line compared to the rest of the industry. AKZA outperforms 54.17% of its industry peers.
AKZA has a Debt/Equity ratio of 0.93. This is a neutral value indicating AKZA is somewhat dependend on debt financing.
AKZA has a Debt to Equity ratio of 0.93. This is in the lower half of the industry: AKZA underperforms 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Altman-Z 2.03
ROIC/WACC0.65
WACC5.7%
AKZA.AS Yearly LT Debt VS Equity VS FCFAKZA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.25 indicates that AKZA should not have too much problems paying its short term obligations.
The Current ratio of AKZA (1.25) is worse than 80.56% of its industry peers.
A Quick Ratio of 0.92 indicates that AKZA may have some problems paying its short term obligations.
The Quick ratio of AKZA (0.92) is worse than 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.92
AKZA.AS Yearly Current Assets VS Current LiabilitesAKZA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

AKZA shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.93%.
The Earnings Per Share has been growing slightly by 4.44% on average over the past years.
The Revenue has decreased by -2.03% in the past year.
Measured over the past years, AKZA shows a small growth in Revenue. The Revenue has been growing by 2.92% on average per year.
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%

3.2 Future

Based on estimates for the next years, AKZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.67% on average per year.
Based on estimates for the next years, AKZA will show a small growth in Revenue. The Revenue will grow by 4.06% on average per year.
EPS Next Y4.39%
EPS Next 2Y8.23%
EPS Next 3Y8.88%
EPS Next 5Y9.67%
Revenue Next Year-3.24%
Revenue Next 2Y-1.87%
Revenue Next 3Y0.61%
Revenue Next 5Y4.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AKZA.AS Yearly Revenue VS EstimatesAKZA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B
AKZA.AS Yearly EPS VS EstimatesAKZA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.53 indicates a correct valuation of AKZA.
Based on the Price/Earnings ratio, AKZA is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.76, AKZA is valued a bit cheaper.
With a Price/Forward Earnings ratio of 12.40, AKZA is valued correctly.
AKZA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AKZA is cheaper than 73.61% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AKZA to the average of the S&P500 Index (23.96), we can say AKZA is valued slightly cheaper.
Industry RankSector Rank
PE 15.53
Fwd PE 12.4
AKZA.AS Price Earnings VS Forward Price EarningsAKZA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

AKZA's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. AKZA is more expensive than 65.28% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AKZA indicates a somewhat cheap valuation: AKZA is cheaper than 70.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 18.38
EV/EBITDA 15.5
AKZA.AS Per share dataAKZA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AKZA does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.54
PEG (5Y)3.49
EPS Next 2Y8.23%
EPS Next 3Y8.88%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.60%, AKZA has a reasonable but not impressive dividend return.
AKZA's Dividend Yield is a higher than the industry average which is at 3.19.
AKZA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.31.
Industry RankSector Rank
Dividend Yield 3.6%

5.2 History

The dividend of AKZA decreases each year by -21.52%.
Dividend Growth(5Y)-21.52%
Div Incr Years0
Div Non Decr Years4
AKZA.AS Yearly Dividends per shareAKZA.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

691.38% of the earnings are spent on dividend by AKZA. This is not a sustainable payout ratio.
DP691.38%
EPS Next 2Y8.23%
EPS Next 3Y8.88%
AKZA.AS Yearly Income VS Free CF VS DividendAKZA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
AKZA.AS Dividend Payout.AKZA.AS Dividend Payout, showing the Payout Ratio.AKZA.AS Dividend Payout.PayoutRetained Earnings

AKZO NOBEL N.V.

AMS:AKZA (12/12/2025, 1:25:35 PM)

56.52

+0.52 (+0.93%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)01-27 2026-01-27/amc
Inst Owners68.31%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap9.67B
Revenue(TTM)10.40B
Net Income(TTM)58.00M
Analysts76.52
Price Target70 (23.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.6%
Yearly Dividend1.98
Dividend Growth(5Y)-21.52%
DP691.38%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.89%
Min EPS beat(2)-7.4%
Max EPS beat(2)-6.38%
EPS beat(4)0
Avg EPS beat(4)-11.39%
Min EPS beat(4)-27.6%
Max EPS beat(4)-4.18%
EPS beat(8)1
Avg EPS beat(8)-8.1%
EPS beat(12)2
Avg EPS beat(12)-11.74%
EPS beat(16)4
Avg EPS beat(16)-11.18%
Revenue beat(2)0
Avg Revenue beat(2)-3.03%
Min Revenue beat(2)-5.13%
Max Revenue beat(2)-0.93%
Revenue beat(4)1
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-5.13%
Max Revenue beat(4)1.79%
Revenue beat(8)1
Avg Revenue beat(8)-1.51%
Revenue beat(12)3
Avg Revenue beat(12)-1.43%
Revenue beat(16)3
Avg Revenue beat(16)-1.57%
PT rev (1m)-1.55%
PT rev (3m)-1.08%
EPS NQ rev (1m)14.62%
EPS NQ rev (3m)4.3%
EPS NY rev (1m)-2.37%
EPS NY rev (3m)-4.71%
Revenue NQ rev (1m)-0.63%
Revenue NQ rev (3m)-0.82%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE 15.53
Fwd PE 12.4
P/S 0.93
P/FCF 18.38
P/OCF 11.39
P/B 2.46
P/tB 66.22
EV/EBITDA 15.5
EPS(TTM)3.64
EY6.44%
EPS(NY)4.56
Fwd EY8.06%
FCF(TTM)3.08
FCFY5.44%
OCF(TTM)4.96
OCFY8.78%
SpS60.83
BVpS22.98
TBVpS0.85
PEG (NY)3.54
PEG (5Y)3.49
Graham Number43.38
Profitability
Industry RankSector Rank
ROA 0.42%
ROE 1.48%
ROCE 5.56%
ROIC 3.7%
ROICexc 4.33%
ROICexgc 8.48%
OM 4.84%
PM (TTM) 0.56%
GM 39.78%
FCFM 5.06%
ROA(3y)3.08%
ROA(5y)4%
ROE(3y)10.07%
ROE(5y)11.29%
ROIC(3y)5.38%
ROIC(5y)6.02%
ROICexc(3y)6.53%
ROICexc(5y)7.21%
ROICexgc(3y)12.06%
ROICexgc(5y)13.03%
ROCE(3y)9.71%
ROCE(5y)10.22%
ROICexgc growth 3Y-10.53%
ROICexgc growth 5Y-0.19%
ROICexc growth 3Y-9.99%
ROICexc growth 5Y-0.31%
OM growth 3Y-9.79%
OM growth 5Y-1.14%
PM growth 3Y-16.36%
PM growth 5Y-2.73%
GM growth 3Y-0.19%
GM growth 5Y-1.09%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 10.17
Debt/EBITDA 4.17
Cap/Depr 86.36%
Cap/Sales 3.1%
Interest Coverage 2.86
Cash Conversion 96.7%
Profit Quality 906.9%
Current Ratio 1.25
Quick Ratio 0.92
Altman-Z 2.03
F-Score5
WACC5.7%
ROIC/WACC0.65
Cap/Depr(3y)80.65%
Cap/Depr(5y)79.09%
Cap/Sales(3y)2.74%
Cap/Sales(5y)2.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.93%
EPS 3Y-1.33%
EPS 5Y4.44%
EPS Q2Q%-11.4%
EPS Next Y4.39%
EPS Next 2Y8.23%
EPS Next 3Y8.88%
EPS Next 5Y9.67%
Revenue 1Y (TTM)-2.03%
Revenue growth 3Y3.76%
Revenue growth 5Y2.92%
Sales Q2Q%-4.54%
Revenue Next Year-3.24%
Revenue Next 2Y-1.87%
Revenue Next 3Y0.61%
Revenue Next 5Y4.06%
EBIT growth 1Y-49.8%
EBIT growth 3Y-6.39%
EBIT growth 5Y1.75%
EBIT Next Year30.22%
EBIT Next 3Y15.72%
EBIT Next 5Y9.68%
FCF growth 1Y-8.04%
FCF growth 3Y4.63%
FCF growth 5YN/A
OCF growth 1Y1.07%
OCF growth 3Y3.41%
OCF growth 5Y96.16%

AKZO NOBEL N.V. / AKZA.AS FAQ

What is the ChartMill fundamental rating of AKZO NOBEL N.V. (AKZA.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to AKZA.AS.


Can you provide the valuation status for AKZO NOBEL N.V.?

ChartMill assigns a valuation rating of 4 / 10 to AKZO NOBEL N.V. (AKZA.AS). This can be considered as Fairly Valued.


How profitable is AKZO NOBEL N.V. (AKZA.AS) stock?

AKZO NOBEL N.V. (AKZA.AS) has a profitability rating of 4 / 10.


How financially healthy is AKZO NOBEL N.V.?

The financial health rating of AKZO NOBEL N.V. (AKZA.AS) is 3 / 10.


What is the earnings growth outlook for AKZO NOBEL N.V.?

The Earnings per Share (EPS) of AKZO NOBEL N.V. (AKZA.AS) is expected to grow by 4.39% in the next year.